Clinical Trial Update: Study to Evaluate D-1553 in Subjects With Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating D-1553 in non-small cell lung cancer has completed enrollment and the study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• D-1553

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: NSCLC | Phase 1, Phase 2 | Status: COMPLETED